Print Email
Study shows elevated rates of inadequate pap tests in transgender men Library/SGIM/About Us/News/01-14FTMCancerScreening_eng.pdf

Cervical cancer can still occur in female-to-male transgender men
A new study finds that female-to-male (FTM) transgender patients had over 10 times higher odds of having an inadequate Papanicolaou (Pap) test compared to female patients. The findings¹, by Fenway Health’s Jennifer Potter, MD, and colleagues at Fenway, Harvard Medical School and the Johns Hopkins School of Public Health, appear in the Journal of General Internal Medicine², published by Springer.